Tonix Pharmaceuticals Holding Corp. (TNXP) is “One to Watch”
Tonix Pharmaceuticals Holding is a specialty pharmaceutical company that lists on the OTC Bulletin Board. The Company is developing therapies for challenging disorders of the central nervous system (CNS), including fibromyalgia syndrome (FM) and post-traumatic stress disorder (PTSD). Tonix focuses on conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. The Company reformulates approved pharmaceutical active ingredients to design products with optimal safety, efficacy, and predictability. Their most advanced product candidates, TNX-102 for FM and TNX-105 for PTSD, are novel dosage formulations of cyclobenzaprine, the active ingredient in two U.S.…